European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Ralf Lohse, Bovenden, Germany

Watch
Ralf Lohse, Bovenden, Germany

If you put a person on your watch list, we'll notify you on your email address when there are new company publications regarding this person.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Network

Portfolio and Investments Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
21 Apr 2023
Reg­is­tra­tion · MD: Ralf Lohse · Change of headquarters: ARGONOPTICS GmbH · Address · Capital: €25,000 · Share­holder agreement · Legal form: GmbH · Name: ARGONOPTICS GmbH · Proxy policy …
31 Jul 2025
Managing Director: Ralf Lohse · No longer Managing Director: Thorsten O. Götze
7 Feb 2022
Managing Director: Ralf Lohse · Change of headquarters: D.I.G GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
11 Apr 2018
Managing Director: Ralf Lohse · No longer MD: Jan Rohlfs · Change of headquarters: Apo Nutrition Verwaltungs GmbH · Address · Capital: €25,000 · Share­holder agreement · Corporate Purpose
2 Dec 2020
Reg­is­tra­tion · Managing Director: Ralf Lohse · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
10 Jun 2022
Reg­is­tra­tion · Managing Director: Ralf Lohse · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
3 Jun 2022
Managing Director: Ralf Lohse · Change of headquarters: Medical Versand GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
17 Jun 2019
Reg­is­tra­tion · Managing Director: Ralf Lohse · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
28 Jan 2026
Managing Director: Daniel Bierbrauer · No longer Managing Director: Ralf Lohse
15 Jul 2021
MD: Ralf Lohse · ppa: Sina Niethmann · No longer MD: Claudia Rohlfs · Change of headquarters: stock 2 GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
18 Mar 2021 as stock 2 GmbH
Reg­is­tra­tion · Managing Director: Ralf Lohse, Claudia Rohlfs · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
11 Mar 2026
Managing Director: Daniel Bierbrauer · No longer Managing Director: Ralf Lohse
8 Aug 2017
Managing Director: Ralf Lohse
15 Sept 2014
Managing Director: Ralf Lohse · Change of headquarters: NÄDLER GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
5 Jul 2021
Managing Director: Ralf Lohse, Udo Wiemers · Change of headquarters: Onko Med GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
11 Dec 2017
Reg­is­tra­tion · Managing Director: Ralf Lohse · Address · Capital: €25,000 · Share­holder agreement · Corporate Purpose
11 Aug 2022
Reg­is­tra­tion · MD: Marc Jeschke, Ralf Lohse · No longer MD: Gabriella Cipra · Change of headquarters: PHARMEC GmbH · Address · Capital: €25,200 · Share­holder agreement · Legal form: GmbH …
7 Jul 2022 as PharmaCare GmbH
MD: Ralf Lohse, Udo Wiemers · No longer MD: Claudia Rohlfs · Change of headquarters: stock 4 GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
1 Jul 2021 as stock 4 GmbH
Reg­is­tra­tion · Managing Director: Ralf Lohse, Claudia Rohlfs · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
27 Jan 2022 as PharmaMed Holding GmbH
Managing Director: Ralf Lohse · Change of headquarters: PharmaMed Holding GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
20 Feb 2020 as PharmaMed Holding GmbH
Reg­is­tra­tion · Managing Director: Ralf Lohse · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
23 Feb 2022
MD: Buleza Koci, Ralf Lohse, Udo Wiemers · ppa: Henrik Justus · Change of headquarters: PharmaMed Dienstleistung GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy …
3 Sept 2020
Reg­is­tra­tion · Managing Director: Ralf Lohse, Udo Wiemers · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
13 Jul 2020 as SGB V GmbH
Managing Director: Ralf Lohse, Jan Rohlfs · Change of headquarters: SGB V GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
19 Feb 2020 as SGB V GmbH
Managing Director: Ralf Lohse
20 May 2019 as Eurozyto Holding GmbH
Managing Director: Ralf Lohse · No longer Managing Director: Joachim H. Winter · Share­holder agreement
22 Apr 2022
MD: Ralf Lohse, Udo Wiemers · No longer MD: Claudia Rohlfs · Change of headquarters: stock 1 GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
22 Mar 2021 as stock 1 GmbH
Reg­is­tra­tion · Managing Director: Ralf Lohse, Claudia Rohlfs · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
13 Jun 2022
Reg­is­tra­tion · Managing Director: Ralf Lohse, Udo Wiemers · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
1 Jun 2022
MD: Ralf Lohse, Udo Wiemers · No longer MD: Claudia Rohlfs · Change of headquarters: stock 3 GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
1 Jul 2021 as stock 3 GmbH
Reg­is­tra­tion · Managing Director: Ralf Lohse, Claudia Rohlfs · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
6 Mar 2019
MD: Ralf Lohse · No longer MD: Heidi Carola Vonhof · Change of headquarters: Kronen zweitausend496 GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
15 Jul 2026
Managing Director: Sina Niethmann · No longer Managing Director: Ralf Lohse · No longer Authorized signatory (ppa): Sina Niethmann
2 Jan 2015
Managing Director: Ralf Lohse · No longer Managing Director (1)

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.